12.97
0.93%
0.12
Handel nachbörslich:
13.25
0.28
+2.16%
Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.54%
2.5372
|
2.836 | 2.5029 | 1.7478 | 2.2411 |
Operating Income/Loss |
10.54%
-2.5372
|
-2.836 | -2.5029 | -1.7478 | -2.2411 |
Income/Loss From Continuing Operations Before Tax |
9.96%
-2.4732
|
-2.7467 | -2.3918 | -1.6284 | -2.1249 |
Income/Loss From Continuing Operations After Tax |
9.96%
-2.4732
|
-2.7467 | -2.3918 | -1.6284 | -2.1249 |
Net Income/Loss
|
9.96%
-2.4732
|
-2.7467 | -2.3918 | -1.6284 | -2.1249 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
12.86
|
- | - | - | - |
Diluted Average Shares |
12.86
|
- | 12.85 | 12.85 | - |
Basic Earnings Per Share |
9.52%
-0.19
|
-0.21 | -0.19 | -0.13 | -0.17 |
Diluted Earnings Per Share |
9.52%
-0.19
|
-0.21 | -0.19 | -0.13 | -0.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):